...
首页> 外文期刊>Journal of Diabetes and Endocrinology >Hepatoprotective and anti-diabetic effect of combined extracts of Moringa oleifera and Vernonia amygdalina in streptozotocin-induced diabetic albino Wistar rats
【24h】

Hepatoprotective and anti-diabetic effect of combined extracts of Moringa oleifera and Vernonia amygdalina in streptozotocin-induced diabetic albino Wistar rats

机译:辣木和杏仁核Vernonia组合提取物对链脲佐菌素诱导的糖尿病白化Wistar大鼠的保肝和抗糖尿病作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

This study was carried out to investigate the hepato-protective properties of combined extracts of?Moringa oleifera?(MO) and?Vernonia amygdalina?(VA) in streptozotocin (STZ) induced diabetic albino Wistar rats. The study design involved 42 rats weighing 120 to 180 g which were divided into 7 groups of 6 rats each. Groups 1 and 2 representing normal and diabetic control (NC and DC) received 0.5 ml of dimethylsulphoxide (DMSO). Group 3 received 5 IU/kg body weight insulin intraperitoneally and group 4 received 5 mg/kg body weight? glibenclamide (GB) orally; groups 5 and 6 received 500 mg/kg body weight of MO and VA, respectively while group 7 the combined treatment group received 250 mg/kg body weight of each extract. After 28 days of treatment, the animals were anaesthetized and sacrificed to obtain blood by cardiac puncture. Serum was collected and assayed for alanine aminotransaminase (ALT), aspartate aminotransferases (AST) and alkaline phosphatase (ALP), total protein (TP) and albumin. The results showed that ALT, AST and ALP levels of the treatment groups decreased significantly (P<0.05) when compared with NC and DC, but were higher than reference drugs. The combined extract significantly (P<0.05) decreased the blood glucose sugar level, and this action compared favourably with the results obtained with the standard drugs. There was a significant increase (P<0.05) in TP and albumin levels of the treatment groups when compared with DC. Fasting blood glucose (FBG) showed significant decrease (P<0.05) in all treated groups compared to NC and DC. Moreover, the body weight change for the treatment groups showed a progressive decrease (P<0.05) except for groups treated with VA and MO when compared with NC. The results thus, show that single and combined extracts of MO and VA has hepatoprotective effects and may be safer in preventing diabetes induced damage to the liver.
机译:进行了这项研究以研究链脲佐菌素(STZ)诱导的糖尿病白化病Wistar大鼠中“油Mo木”(MO)和“油曲霉”(VA)联合提取物的保肝性能。研究设计涉及42只体重120至180 g的大鼠,将其分成7组,每组6只。代表正常和糖尿病对照组(NC和DC)的第1组和第2组接受0.5 ml的二甲基亚砜(DMSO)。第3组腹膜内接受5 IU / kg体重的胰岛素,第4组接受5 mg / kg体重?口服格列本脲(GB);第5和第6组分别接受500 mg / kg体重的MO和VA,而第7组联合治疗组接受每种提取物250 mg / kg体重。治疗28天后,将动物麻醉并处死以通过心脏穿刺获得血液。收集血清并测定丙氨酸氨基转氨酶(ALT),天冬氨酸氨基转移酶(AST)和碱性磷酸酶(ALP),总蛋白(TP)和白蛋白。结果显示,与NC和DC相比,治疗组的ALT,AST和ALP水平显着降低(P <0.05),但高于参考药物。合并的提取物显着(P <0.05)降低了血糖水平,与标准药物获得的结果相比,该作用具有优势。与DC相比,治疗组的TP和白蛋白水平显着增加(P <0.05)。与NC和DC相比,所有治疗组的空腹血糖(FBG)均显着降低(P <0.05)。此外,与NC相比,除接受VA和MO治疗的组外,治疗组的体重变化均显示出逐渐降低(P <0.05)。因此,结果表明,MO和VA的单一和组合提取物具有保肝作用,在预防糖尿病引起的肝损害方面可能更安全。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号